CRYAB was also identified as a downstream effector of calcineurin-induced protection against cardiomyocyte apoptosis (Bousette et al., 2010) and a molecular switch in bypassing mitochondrial pathway of apoptosis during myocardial infarction (Mitra et al., 2013). Here, CRYAB is linked to myocardial infarction.